VANTAI
VantAI builds computational models that identify hidden links between molecules, targets, and diseases by combining the machine learning approach with deep systems biology expertise. From the deep analysis of systems-based pharmacogenomics, these models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME, and toxicological insights, and predicts adverse events likely to influence trial success. In addition to small-molecule therapeutics, VantAI's in silico platform excels in simulating complicated protein-protein interactions, enabling the discovery of biologics and protein degraders.
VANTAI
Industry:
Alternative Medicine Artificial Intelligence (AI) Biotechnology Clinical Trials Life Science Machine Learning Pharmaceutical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.vant.ai
Total Employee:
11+
Status:
Active
Contact:
+1 347 633 3580
Email Addresses:
[email protected]
Technology used in webpage:
Amazon Mobile Non Scaleable Content IPv6 JsDelivr UNPKG Google Identity Platform Google Cloud Global Multi-Region Apollo GraphQL AWS Cloudfront Los Angeles CA Edge Heap
Similar Organizations
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
GiwoTech
AI company building life simulators
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Oncoceutics
Oncoceutics, Inc. is a drug discovery and development company targeting the most potent suppressor pathways in human cancer.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Pera Labs
Pera Labs develops digiceuticals and AI-powered solutions for fertility.
Sorintellis
AI-powered pharmaceutical portfolio management.
Current Employees Featured
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-08 | VantAI Appoints John Cuozzo as Senior Vice President, Head of Drug Discovery |
Official Site Inspections
http://www.vant.ai Semrush global rank: 3.93 M Semrush visits lastest month: 2.85 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "VantAI"
Vant
May 1, 2024 · VantAI, a company focused on generative AI-enabled drug discovery, today announced the appointments of Dr. Ian Churcher and Dr. Bradley Pentelute to its Scientific …See details»
An Integrated Discovery Platform - vant.ai
…built to unlock the full potential of the proximity modulator modality. Working With Industry Leaders. BUILD THE FUTURE WITH USSee details»
VantAI - Crunchbase Company Profile & Funding
VantAI build computational models, relationships between molecules, targets, and diseases. View contacts for VantAI to access new leads and connect with decision-makers.See details»
VantAI - Overview, News & Similar companies | ZoomInfo.com
VantAI contact info: Phone number: +54 3424695740 Website: www.vant.ai What does VantAI do? VantAI leverages the cell's most powerful systems through rationally-designed small …See details»
Org Chart Vant AI - The Official Board
The organizational chart of Vant AI displays its 16 main executives including Zachary Carpenter, Cindy Liu and Matthias Grass Toggle navigation The Official Board SearchSee details»
VantAI Secures Renewed Support from Blueprint …
Jan 9, 2024 · Leveraging VantAI's sophisticated geometric deep learning-based AI platform, VantAI and Blueprint Medicines aspire to create innovative molecular glue candidates that extend beyond the ...See details»
VantAI Announces Formation of Scientific Advisory Board - Yahoo …
NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- VantAI, a leading company focused on the application of artificial intelligence to drug discovery, today announced its newly formed …See details»
VantAI Forms Research Collaboration with Boehringer …
Apr 20, 2022 · NEW YORK and INGELHEIM, Germany, April 20, 2022 (GLOBE NEWSWIRE) -- VantAI, an AI-first induced-proximity company, and Boehringer Ingelheim today announced that the two companies have entered...See details»
VantAI - workinbiotech.com
VantAI is at the forefront of artificial intelligence (AI) research, aiming to “program” protein interactions. Specializing in computational biology and machine learning, VantAI combines …See details»
Our Team - Vant
AI SCIENTIST III. Thomas Castiglione. AI SCIENTIST II. Leo Klarner. AI SCIENTIST INTERN. Marco Pegoraro. AI SCIENTIST INTERN. Cristina Di Genua. DIRECTOR. PLATFORM …See details»
VantAI - VentureRadar
Website: https://www.vant.ai/ Offers advanced computational models using machine learning and systems biology expertise to discover new molecular entities, repurpose existing molecules, …See details»
VantAI Enters Collaboration With Bristol Myers Squibb to ... - Nasdaq
Feb 13, 2024 · VantAI is eligible to receive up to $674 million in discovery, development, clinical, regulatory, and sales milestone payments plus tiered royalties from Bristol Myers Squibb, with …See details»
VantAI Announces Multi-Year Protein Degrader Discovery …
Apr 13, 2022 · VantAI is a wholly-owned subsidiary of Roivant Sciences (Nasdaq: ROIV). For more information, please visit http://www.vant.ai.See details»
Our Mission - Vant
VantAI, a company focused on generative AI-enabled drug discovery, today announced the appointments of Dr. Ian Churcher and Dr. Bradley Pentelute to its Scientific Advisory Board …See details»
Press Releases - Vant
VantAI, a company focused on generative AI-enabled drug discovery, and Bristol Myers Squibb, a leading pharmaceutical company, have entered into a strategic collaboration to discover new …See details»
Working at VantAI - Glassdoor
Glassdoor gives you an inside look at what it's like to work at VantAI, including salaries, reviews, office photos, and more. This is the VantAI company profile. All content is posted anonymously …See details»
[2411.17451] VLRewardBench: A Challenging Benchmark for
1 day ago · Vision-language generative reward models (VL-GenRMs) play a crucial role in aligning and evaluating multimodal AI systems, yet their own evaluation remains under …See details»
VantAI Enters Collaboration With Bristol Myers Squibb to …
NEW YORK, February 13, 2024 -- (BUSINESS WIRE)-- VantAI, a company focused on generative AI-enabled drug discovery, and Bristol Myers Squibb (NYSE: BMY), a leading …See details»
AI Chat - DeepAI
AI Chat is an AI chatbot that writes text. You can use it to write stories, messages, or programming code. You can use the AI chatbot as a virtual tutor in almost any subject.See details»
Apply Today - Vant
Utilize your skills to help us tackle some of the most complex and meaningful scientific challenges on the planet. We are seeking a highly motivated and experienced Senior Project Manager to …See details»